-
Markets
-
Equities
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesRead moreTrade mini bond futures on main European government bonds
-
Commodities
- Overview
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesRead moreEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Omda wins long term contract with Karolinska University Hospital
22 Apr 2025 12:34 CEST
Issuer
Omda AS
Karolinska University Hospital has chosen Omda ProSang as their future blood
establishment software platform.
Karolinska University Hospital in Stockholm has long been a user of the blood
establishment solution Omda ProSang, but in 2024, they explored the
international market to identify the very best solution for their future needs.
On April 10, 2025, Karolinska and Omda signed an 8-year contract, including an
option for an additional extension of up to 4 years.
Daniel Wiman, Business Unit Leader for Blood Establishment at Omda, is delighted
that Omda ProSang continues to maintain its leading position in the Nordic
region while also demonstrating strong competitiveness against international
solutions:
"Omda ProSang has been trusted for over 50 years, evolving technologically while
deeply embedded in the professional blood management community across the
Nordics. Having won the national procurement in Denmark in 2021 and now securing
the Karolinska contract in 2025, I can confidently say our solution remains the
best in the world in this field."
The extensive history of Omda ProSang highlights why customers prefer long-term
contracts, as Wiman explains:
"Our software supports complex processes where quality and predictability are
essential for critical institutions like Karolinska. For Omda, this translates
into both financial stability and invaluable opportunities to collaborate with
some of the world's leading professional environments."
Karolinska has publicly announced the financial scope of the contract, valued at
50 MSEK, with additional options totalling 35 MSEK.
About Omda ProSang
Omda ProSang is an advanced Laboratory Information Management System (LIMS) that
supports all areas of blood, cell and tissue management with full traceability
from donor to recipient. The system is utilised by blood donors and in blood
centres, immunohematology laboratories, clinical immunology laboratories,
transplantation laboratories, tissue establishments, and stem cell facilities.
Omda ProSang has provided full ISBT 128 support for decades and is trusted by
more than 180 blood centres in five countries.
For more information, please contact:
Daniel Wiman,
Business Unit Leader, Blood Establishment
+46 70-482 77 57
daniel.wiman@omda.com
About Omda
Omda is the leading provider of specialised software for healthcare and
emergency services in the Nordics with a growing presence in Europe, North
America and the Pacific region. The company has more than 600 contracts in 27
countries and employs more than 250 dedicated specialists. Our highly
specialised healthcare solutions empower medical professionals and emergency
responders, enabling them to know more and work smarter. With a focus on
user-centric design, value-driven development and close working relationships
with customers, Omda delivers solutions that enhance patient safety and improve
healthcare outcomes.
For more information, visit www.omda.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH
More information:
Access the news on Oslo Bors NewsWeb site
Source
Omda AS
Provider
Oslo Børs Newspoint
Company Name
Omda AS 23/28 FRN FLOOR C, OMDA AS
ISIN
NO0013075721, NO0010894512
Symbol
OMDA
Market
Nordic Alternative Bond Market Euronext Growth